Phio Pharmaceuticals Corp. Banner Image

Phio Pharmaceuticals Corp.

  • Ticker PHIO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Phio Pharmaceuticals Corp. Logo Image
  • 11-50 Employees
  • Based in Marlborough, Massachusetts
Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYLâ„¢) therapeutic platform. The Company's efforts are focused on silencing tumor-induced suppression of the immune system through its proprietary INTASYL platform with utility in immune cells and the tumor micro-environmentMore. Their goal is to develop powerful INTASYL therapeutic compounds that can weaponize immune effector cells to overcome tumor immune escape, thereby providing patients a powerful new treatment option that goes beyond current treatment modalities.
4.8 / 5.0 (74)

Phio Pharmaceuticals Corp. reports have an aggregate usefulness score of 4.8 based on 74 reviews.

Phio Pharmaceuticals Corp.

Most Recent Annual Report

Phio Pharmaceuticals Corp.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Phio Pharmaceuticals Corp. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!